Zensar Technologies, Shalby and Tata Motors to see some action today

The Ramco Cements Ltd. | Cement & Construction Materials | Construction & Infrastructure | BSE: 500260 | NSE: RAMCOCEM

17 May 2021 Evaluate

Zensar Technologies’ wholly owned subsidiary -- Zensar Technologies Inc, USA, has entered into definitive agreement(s)/document(s) for acquisition of 100% of the membership interests in M3bi, LLC, USA. Further, the Board of Directors, inter-alia, approved/concurred/consented to acquisition of M3bi India, and accordingly the company has entered into definitive agreement(s)/document(s) for acquisition of entire equity share capital of M3bi India, subsidiary of M3bi, LLC, USA. Zensar and M3BI can jointly leverage the entire range of Zensar’s services for M3bi’s marquee clients.

Shalby has entered into a definitive agreement to acquire certain assets from Consensus Orthopedics (Consensus) a company headquartered in El Dorado Hills, Sacramento, California for a cash consideration of $ 11.45 million. The assets were acquired by Shalby Advanced Technologies Inc, a wholly owned subsidiary of Mars Medical Devices, which in turn is a wholly owned subsidiary of Shalby.

In its constant endeavor to accelerate EV adoption in the country, Tata Motors and Tata Power have recently inaugurated a high-speed CCS2 EV charging station at Dada Motors in Ludhiana. With this, the company operates the largest charging network of 4 chargers in Ludhiana and 6 throughout Punjab, located on major routes. All Tata EV customers can now travel carefree to and from Ludhiana and Mohali, which are some of the major industrial cities in Punjab.

Max Ventures & Industries’ (MaxVIL) subsidiary -- Max Speciality Films (MSFL) is planning to invest upto Rs 500 million in a new CPP Line which will have a capacity of 7.2 KTPA (Kilo Tonnes Per Annum). The new CPP Line expansion will be funded entirely through internal accruals. Work on the capex will commence in Q2FY22 and is expected to be commercialized in Q2FY23. Demand for the CPP Films has been robust and expanding the capacity will enable MSFL to cater to the growing market for such films.

Ramco Cements has commissioned medical oxygen plant at its factory in Ramasamy Raja Nagar in Tamil Nadu, for the welfare of common people. The plant established at a cost of Rs 50 lakh has a production capacity of 48 numbers of oxygen cylinders per day. Each cylinder has a capacity of 45 liters of liquid oxygen, which is equal to 7000 liters in gaseous form. At the rate of 10 liters per minute, one cylinder can feed one patient for 10 to 12 hours. With this continuous supply of medical oxygen from this plant, around 24 lives can be saved every day.

Granules India has earmarked a capex of around Rs 1,000 crore which it aims to invest over the next three financial years on a new manufacturing facility and on expanding production capacities at existing plants. During FY22, it expects to spend Rs 400 crore and the rest of the Rs 600 crore is spread over FY23 and FY24.

Sagarsoft (India) has received board’s approval for proposed acquisition of 100% stake in IT CATS, LLC, USA. The Board of Directors of the company at their meeting held on May 14, 2021, inter-alia, accorded its in-principle approval for proposed acquisition, subject to completion of valuation, satisfactory diligence and all other applicable statutory and regulatory approvals/compliances as may be required for the purpose, post which the Board shall reconsider the matter for its final approval.

The Ramco Cements Share Price

1011.45 10.30 (1.03%)

17-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
Ultratech Cement	11887.30
Ambuja Cement	458.95
ACC	1431.85
Shree Cement	25301.95
Dalmia Bharat	1972.55
View more..

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Zensar Technologies, Shalby and Tata Motors to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.